VEGFA and neoplasm: No tumour-related deaths occurred in 18 dogs with a low VEGF/type 3 decorin combination, compared to 6/12 (50%) deaths in STS with a high VEGF/type 1 decorin combination (log rank 16.7, p = 0.005).